<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00122135</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 02-224</org_study_id>
    <nct_id>NCT00122135</nct_id>
  </id_info>
  <brief_title>A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making</brief_title>
  <acronym>Aim3</acronym>
  <official_title>A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this research agenda is to improve the quality of end-of-life care by explicitly
      identifying values that will guide the decision-making process, with a particular emphasis on
      the role of ethnic, racial and cultural factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: End-of-life decision-making is an important aspect of providing quality
      healthcare, especially for the elderly population. Increasingly, the appropriateness of many
      of these decisions is being questioned. Some invasive procedures done in seriously ill
      patients do not significantly alter their course, many patients die without having pain or
      other symptoms addressed, and families may feel dissatisfied with the care provided.
      Additionally, there are striking racial/ethnic disparities in end-of-life care.

      Objectives: The explicit identification of values that guide medical decision-making could
      improve the decision-making process for end-of-life care for patients of all
      races/ethnicities. 1) We will directly compare, critically assess, and revise two Values
      Histories on the basis of qualitative data derived from individual interviews with
      racially/ethnically diverse patients and surrogates, and explore patients', surrogates', and
      physicians' values, preferences and concerns that guide decision-making about medical
      interventions at the end-of-life. 2) We will then adapt the existing Values Histories into a
      clinically practical tool, the Values Inventory discussion aid. 3) We will conduct
      preliminary testing of this tool to be used in physician-patient or physician-surrogate
      encounters to improve and facilitate decisions about end-of-life care.

      Methods: To complete Objective 3 we will conduct a pilot randomized trial of the developed
      Values Inventory discussion aid to test the feasibility of using it in clinical practice.
      This clinicaltrials.gov number applies to Objective 3 of IIR-02-224 only (as the complete
      study is a mixed-methods study with several different arms and enrollment goals). Eligible
      patients are at risk for 6-12-month mortality with one of the following diagnoses: congestive
      heart failure, with ejection fraction of less than 25%; severe chronic obstructive pulmonary
      disease/emphysema with dependence on oxygen; chronic liver disease with cirrhosis and
      ascites; colon carcinoma with liver metastases; or non-small cell cancer of the lung, stage
      III or IV, and patients with chronic kidney disease on renal replacement therapy, with
      previous hospitalization. All (patient) participants are age 55 years or older and are
      recruited through the clinics/wards at the Houston VAMC. Surrogates are surrogates of
      patients with such conditions; physicians are generalists and medical subspecialists. All
      participants are African American, Hispanic, or White, reflecting the 3 major
      races/ethnicities at the Houston VAMC.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of Discussions About End of Life Care Goals/Wishes</measure>
    <time_frame>immediate</time_frame>
    <description>Qualitative content analysis of physician-patient encounters regarding presence of any type of discussion about end of life care goals/wishes</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Congestive Heart Failure</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Cirrhosis</condition>
  <condition>Colon Carcinoma</condition>
  <condition>Lung Cancer</condition>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Patients without Values Inventory (VI)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Clinic encounter w/physician &amp; patient and/or surrogate - Patients who did not receive the VI prior to their physician clinic encounter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Values Inventory (VI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinic encounter w/physician &amp; patient and/or surrogate - Patients who completed the VI prior to their physician clinic encounter</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Values Inventory (VI)</intervention_name>
    <description>The Values Inventory was given to patients for self-administration while they were awaiting their clinic appointment. They were instructed to bring it to their physician's attention right at the beginning of their clinic visit.</description>
    <arm_group_label>Patients with Values Inventory (VI)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible patients will be at risk for 6-12 month mortality and have one of the
             following diagnoses:

               -  congestive heart failure, with ejection fraction of &lt;25%;

               -  severe chronic obstructive pulmonary disease/emphysema with dependence on oxygen;

               -  chronic liver disease with cirrhosis and ascites;

               -  colon carcinoma with liver metastases; or

               -  non-small cell cancer of the lung, stage III or IV

               -  chronic kidney disease on renal replacement therapy, with previous
                  hospitalization

          -  All participants will be age 55 years or older and will be recruited through the
             clinics at the Houston VAMC.

        Exclusion Criteria:

          -  Patients with dementia

          -  Patients less than 55 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula K. Braun, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michael E DeBakey VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Michael E DeBakey VA Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Braun UK, Beyth RJ, Ford ME, McCullough LB. Defining limits in care of terminally ill patients. BMJ. 2007 Feb 3;334(7587):239-41. Review.</citation>
    <PMID>17272566</PMID>
  </results_reference>
  <results_reference>
    <citation>Braun UK, Beyth RJ, Ford ME, McCullough LB. Voices of African American, Caucasian, and Hispanic surrogates on the burdens of end-of-life decision making. J Gen Intern Med. 2008 Mar;23(3):267-74. doi: 10.1007/s11606-007-0487-7. Epub 2008 Jan 3.</citation>
    <PMID>18172738</PMID>
  </results_reference>
  <results_reference>
    <citation>Braun UK, Kunik ME, Pham C. Treating depression in terminally ill patients can optimize their physical comfort at the end of life and provide them the opportunity to confront and prepare for death. Geriatrics. 2008 Jun;63(6):25-7. Review.</citation>
    <PMID>18512998</PMID>
  </results_reference>
  <results_reference>
    <citation>Braun UK, McCullough LB, Beyth RJ, Wray NP, Kunik ME, Morgan RO. Racial and ethnic differences in the treatment of seriously ill patients: a comparison of African-American, Caucasian and Hispanic veterans. J Natl Med Assoc. 2008 Sep;100(9):1041-51.</citation>
    <PMID>18807433</PMID>
  </results_reference>
  <results_reference>
    <citation>Braun UK, Naik AD, McCullough LB. Reconceptualizing the experience of surrogate decision making: reports vs genuine decisions. Ann Fam Med. 2009 May-Jun;7(3):249-53. doi: 10.1370/afm.963.</citation>
    <PMID>19433843</PMID>
  </results_reference>
  <results_reference>
    <citation>Braun UK, Ford ME, Beyth RJ, McCullough LB. The physician's professional role in end-of-life decision-making: voices of racially and ethnically diverse physicians. Patient Educ Couns. 2010 Jul;80(1):3-9. doi: 10.1016/j.pec.2009.10.018. Epub 2009 Nov 30.</citation>
    <PMID>19948388</PMID>
  </results_reference>
  <results_reference>
    <citation>Braun UK, Ford ME, McCullough L, Beyth RJ. Discussing End-of-Life Decision Making: Views of Racially and Ethnically Diverse Physicians. [Abstract]. The Journal of Nutrition, Health &amp; Aging. 2006 Aug 1; 10(4):332.</citation>
  </results_reference>
  <results_reference>
    <citation>Nambiar A, McCullough L, Ford M, Beyth R, Braun UK. Discussing End-of-Life Decision Making: Views of Racially and Ethnically Diverse Physicians. [Abstract]. The Gerontologist. 2006 Oct 1; 46(Special Issue 1):402.</citation>
  </results_reference>
  <results_reference>
    <citation>Braun U, Morgan RO, Ford ME, Beyth RJ. Who gets what? Race/ethnicity matter for treatment of seriously ill veterans. [Abstract]. Journal of the American Geriatrics Society. 2006 Apr 1; 54(S4):S180.</citation>
  </results_reference>
  <results_reference>
    <citation>Braun U, McCullough L, Ford M, Espadas D, Beyth R. End-of-life care across race and ethnicities: Voices of patients, surrogates, and physicians. [Abstract]. Journal of the American Geriatrics Society. 2005 Apr 1; 53(s1):S137-8.</citation>
  </results_reference>
  <results_reference>
    <citation>Pham C, Braun UK. Racial and Ethnic Differences in End-of-Life Care for Patients with End-Stage Renal Disease. [Abstract]. Journal of pain and symptom management. 2009 Mar 1; 37(3):556-557.</citation>
  </results_reference>
  <results_reference>
    <citation>Braun UK, Beyth RJ, Ford ME, Espadas D, McCullough LB. Decision-making styles of seriously ill male Veterans for end-of-life care: Autonomists, Altruists, Authorizers, Absolute Trusters, and Avoiders. Patient Educ Couns. 2014 Mar;94(3):334-41. doi: 10.1016/j.pec.2013.10.013. Epub 2013 Nov 19.</citation>
    <PMID>24365071</PMID>
  </results_reference>
  <results_reference>
    <citation>Braun UK, McCullough LB. Preventing life-sustaining treatment by default. Ann Fam Med. 2011 May-Jun;9(3):250-6. doi: 10.1370/afm.1227.</citation>
    <PMID>21555753</PMID>
  </results_reference>
  <results_reference>
    <citation>Menon S, McCullough LB, Beyth RJ, Ford ME, Espadas D, Braun UK. Feasibility of Using a Values Inventory as a Discussion Aid about End-of-Life Care. Poster session presented at: Gerontological Society of America Annual Scientific Meeting; 2010 Nov 21; New Orleans, LA.</citation>
  </results_reference>
  <results_reference>
    <citation>Menon S, McCullough LB, Beyth RJ, Ford ME, Espadas D, Braun UK. Use of a values inventory as a discussion aid about end-of-life care: A pilot randomized controlled trial. Palliat Support Care. 2016 Aug;14(4):330-40. doi: 10.1017/S1478951515001091. Epub 2015 Oct 13.</citation>
    <PMID>26458331</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2005</study_first_submitted>
  <study_first_submitted_qc>July 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2005</study_first_posted>
  <results_first_submitted>July 10, 2015</results_first_submitted>
  <results_first_submitted_qc>October 6, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 10, 2015</results_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>end-of-life care</keyword>
  <keyword>clinical decision-making</keyword>
  <keyword>values inventory</keyword>
  <keyword>racial disparities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Patients With VI</title>
          <description>patients / surrogates who did receive the Values Inventory prior to their clinic appointment
Values history discussion w/physician &amp; patient/surrogate: 128 patient/physician values history discussions were taped, also 4 case studies with surrogates were completed.</description>
        </group>
        <group group_id="P2">
          <title>Patients Without VI</title>
          <description>Patients who did not receive the Values Inventory prior to their clinic visit</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patients With VI</title>
          <description>Patients who filled out the Values History prior to their clinic appointment</description>
        </group>
        <group group_id="B2">
          <title>Patients Without VI</title>
          <description>Patients who did not receive the Values History prior to their clinic appointment (usual care)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
            <count group_id="B2" value="60"/>
            <count group_id="B3" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.4" lower_limit="55" upper_limit="85"/>
                    <measurement group_id="B2" value="68.4" lower_limit="56" upper_limit="84"/>
                    <measurement group_id="B3" value="67.4" lower_limit="55" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Presence of Discussions About End of Life Care Goals/Wishes</title>
        <description>Qualitative content analysis of physician-patient encounters regarding presence of any type of discussion about end of life care goals/wishes</description>
        <time_frame>immediate</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With VI</title>
            <description>Patients who filled out the Values History prior to their clinic appointment</description>
          </group>
          <group group_id="O2">
            <title>Patients Without VI</title>
            <description>Patients who did not receive the Values History prior to their clinic appointment (usual care)</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Discussions About End of Life Care Goals/Wishes</title>
          <description>Qualitative content analysis of physician-patient encounters regarding presence of any type of discussion about end of life care goals/wishes</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.77</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>There was only a one-time physician-patient encounter for this minimum risk study and any adverse event would have been reported immediately on the day of the encounter. There was no systematic assessment for AE.</time_frame>
      <desc>No patient reported an adverse event at the time of the study (immediately before/after physician - patient encounter. Nobody reported any adverse events later to study personnel.</desc>
      <group_list>
        <group group_id="E1">
          <title>Patients With VI</title>
          <description>Clinic encounter w/physician &amp; patient and/or surrogate - Patients who completed the VI prior to their physician clinic encounter
Clinic encounter w/physician &amp; patient and/or surrogate: 128 patient/physician values history discussions were taped, also 4 case studies with surrogates were completed.</description>
        </group>
        <group group_id="E2">
          <title>Patients Without VI</title>
          <description>Clinic encounter w/physician &amp; patient and/or surrogate - Patients who did not receive the VI prior to their physician clinic encounter
Clinic encounter w/physician &amp; patient and/or surrogate: 128 patient/physician values history discussions were taped, also 4 case studies with surrogates were completed.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Difficulties in recruiting enough surrogates led to abandoning having a surrogate arm.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Ursula Braun</name_or_title>
      <organization>Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX</organization>
      <phone>832 687 1645</phone>
      <email>ubraun@bcm.edu; ursula.braun@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

